Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the launch of Notetaker, an AI-powered clinical assistant ...

A new bone marrow test can help doctors predict risk of leukemia relapse. The test might double survival rates by predicting ...

RFK Jr. wants placebo trials for vaccines. A Northwestern researcher says that's unethical.

Last time there was no status LED included in the design, and the recessed reset switch and micro-USB power input were on ...

This internal calmness gradually extends to a more enlightened approach to life's challenges. In a world that never stops ...

Q1 2025 Earnings Call Transcript May 1, 2025 X4 Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $4.0E-5, ...

Jim Szyperski is the CEO of Acuity Behavioral Health, a company redefining inpatient psychiatric care through data-driven ...

When leveraged to their appropriate context and strengths, under the care of an oncologist, cancer-related apps can actually strengthen the bond with the physician and care team, while empowering the ...

Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...

While chemotherapy, radiation and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some ...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...

Q1 2025 - Earnings Conference Call April 30, 2025 8:00 AM ETCompany ParticipantsLisa Stoner - VP, IRJames Rechtin - President, ...